- Record: found
- Abstract: found
- Article: not found
Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To evaluate the outcome of intravitreal injection of aflibercept in cases with exudative age-related macular degeneration, (AMD) resistant to injections of bevacizumab or ranibizumab.